Category: Nanomedicine
Nanomedicine market research reports by Frost & Sullivan
-
Global Orphan Drug Growth Opportunities
Global Orphan Drug Growth Opportunities Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions In this study, Frost & Sullivan’s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights grow ... Read More
-
Post-pandemic Healthcare Business Models in APAC—2023
Post-pandemic Healthcare Business Models in APAC—2023 Innovative Business Models and Case Studies The COVID-19 pandemic and the shift toward value-based care have highlighted the need for more flexible and resilient healthcare systems, creating opportunities for innovative business models. Several c ... Read More
-
Lipid-based Nanoparticles for the Pharmaceutical Industry: Pre-clinical and Clinical Advancements
Lipid-based Nanoparticles for the Pharmaceutical Industry: Pre-clinical and Clinical Advancements In the last decade, nanomedicine and nanotechnology have helped unlock revolutionary therapeutic potential that has positively impacted healthcare. Among the different nanotechnology-based innovations, ... Read More